Payapwattanawong S, Osterlund E, Vetere G, Bent AH, Dasari A, Kee BK, Parseghian C, Willis J, YC Shen JP, Singh Raghav KP, Eluri M, Morelli MP, Overman MJ, Le P, Huey RW, Martinez SA, Higbie V, Shen X, Van K Morris II, Kopetz S
Argmann CA, Sawyez CG, Li S, Nong Z, Hegele RA, Pickering JG, Huff MW
Peripheral administration of recombinant FGF1 in hyperglycemic mice produces robust glucose control and enhanced insulin sensitivity, actions dissociated from changes in cell proliferation, weight gain, or bone loss [27]
Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments
According to ASPS 2026 trend statistics, fat transfer is an important part of several GLP-1 makeover operations